Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2268 results about "Saponin" patented technology

Saponins a class of chemical compounds found in particular abundance in various plant species. More specifically, they are amphipathic glycosides grouped phenomenologically by the soap-like foam they produce when shaken in aqueous solutions, and structurally by having one or more hydrophilic glycoside moieties combined with a lipophilic triterpene or steroid derivative.

Pediococcus acidilactici N6-3 and application thereof in preparing rare ginsenoside by fermenting and converting ginsenoside Rb1

The invention discloses pediococcus acidilactici N6-3 and application thereof in preparing rare ginsenoside by fermenting and converting ginsenoside Rb1, and relates to the field of probiotic fermentation. The pediococcus acidilactici N6-3 is preserved in the China Center for Type Culture Collection on September 18, 2024, and the preservation number of the pediococcus acidilactici N6-3 is CCTCC NO: M 20241999. The high-yield beta-glucosidase pediococcus acidilactici N6-3 which is independently separated and identified can be used for fermenting and converting a ginsenoside monomer Rb1. In the preparation process of the rare ginsenoside, the method does not need the combination of treatment modes such as alkaline hydrolysis, high temperature and high pressure, steam treatment and the like, and has the advantages of mild reaction, environmental protection, low cost and short fermentation time. After fermentation, ginsenoside monomers Rb1 can be completely converted into rare ginsenoside 20 (R)-Rg3, 20 (S)-Rg3, Rk1 and Rg5, and a new way is provided for preparing rare ginsenoside by converting ginsenoside Rb1 through fermentation of pediococcus acidilactici.
Owner:JILIN AGRICULTURAL UNIV

Red ginseng fermentation liquor with high rare saponin content and high functional biological activity and preparation method of red ginseng fermentation liquor

The invention discloses red ginseng fermentation liquor with high rare saponin content and functional bioactivity and a preparation method thereof, and the preparation method comprises the following steps: mixing red ginseng powder with water to obtain red ginseng mixed liquor; cellulase is added into the red ginseng mixed solution for enzymolysis, and red ginseng enzymatic hydrolysate is obtained; or heating the red ginseng liquid, and performing hot water extraction to obtain a red ginseng extracting solution; heating the red ginseng extracting solution to be boiled, and after sterilization is finished, adding lactic acid bacteria powder for fermentation after the red ginseng solution is cooled, so as to obtain red ginseng fermentation liquor; and carrying out solid-liquid separation on the fermentation broth to obtain a fermentation supernatant, and sterilizing the red ginseng fermentation broth to obtain the sterilized red ginseng fermentation broth. According to the preparation method disclosed by the invention, the content of total saponins in the red ginseng fermentation liquor is increased, the variety and content of rare saponins can be increased, and in addition, the prepared red ginseng fermentation liquor has relatively high antioxidant activity, tyrosinase inhibition rate activity, leukoproteinase inhibition activity and hyaluronidase inhibition activity; wide application prospects and market potentials are realized.
Owner:XIAMEN YUANZHIDAO BIOTECHNOLOGY CO LTD

Polygonatum sibiricum fermentation product as well as preparation method and application thereof

The invention provides a preparation method of a polygonatum sibiricum fermentation product, which comprises the following steps: A) pretreating a polygonatum sibiricum raw material, and mixing with water to obtain polygonatum sibiricum slurry; b) heating the polygonatum sibiricum slurry, mixing the heated polygonatum sibiricum slurry with a nitrogen source and a phosphorus source, and performing primary sterilization to obtain sterilized polygonatum sibiricum slurry; c) inoculating the sterilized rhizoma polygonati slurry with saccharomycetes, and fermenting to obtain fermentation liquor; d) adding a carbon source into the fermentation liquor, performing secondary sterilization, inoculating lactic acid bacteria, performing secondary fermentation, and performing third sterilization to obtain secondary fermentation liquor; and E) adding a compound enzyme into the secondary fermentation liquid for enzymolysis, then sterilizing for four times, and centrifuging to obtain the polygonatum sibiricum fermentation product. 3000 Da), a small molecule polypeptide (lt; the polygonatum kingianum fermentation product prepared by the method disclosed by the invention has the advantages that the conversion of polygonatum kingianum saponin can be promoted, the contents of diosgenin and trilliin are increased and calibrated, and the polygonatum kingianum fermentation product has the effects of improving the reaction capability and the exercise capability.
Owner:ANGEL YEAST CO LTD +1

Fermented lactobacillus mucus NJ-10 and application thereof in preparation of rare ginsenoside-rich metagen through fermentation conversion

The invention discloses fermented lactobacillus mucus NJ-10 and application thereof in preparation of rare ginsenoside-rich metagen through fermentation conversion, and relates to the field of probiotic fermentation. The lactobacillus fermentum NJ-10 is preserved in the China Center for Type Culture Collection on February 25, 2025, and the preservation number of the lactobacillus fermentum NJ-10 is CCTCC (China Center for Type Culture Collection) NO: M 2025300. According to the present invention, the fermentation lactobacillus mucus NJ-10 capable of producing beta-glucosidase, which is subjected to autonomous separation and identification, can be used for fermentation and conversion of ginseng stem and leaf saponin, and then is subjected to post-generation preparation in a high-temperature and high-pressure steam manner, such that the beta-glucosidase producing beta-glucosidase can be produced, and the beta-glucosidase producing beta-glucosidase producing beta-glucosidase producing beta-glucosidase producing beta-glucosidase producing beta-glucosidase can be produced. According to the method, ginseng stem and leaf saponin is converted through two-step fermentation to prepare the postbiotic fermentation product rich in rare ginsenoside, resource utilization of non-medicinal parts of ginseng is expanded, and the postbiotic fermentation product has wide application prospects in the fields of food industry, pharmaceutical industry, cosmetics, animal breeding and the like.
Owner:JILIN AGRICULTURAL UNIV

Rare saponin-rich ginseng extract as well as preparation method and application thereof

The invention discloses a ginseng extract rich in rare saponins and preparation and anti-aging application thereof, and belongs to the technical field of oral beauty and skin care products, the ginseng extract is obtained by fermentation treatment of ginseng powder through phytobacterium plantarum, and the preservation number of the phytobacterium plantarum is GDMCC No.64374. The ginseng extract rich in rare saponin is fermented by specific plant lactobacillus, ginsenoside is efficiently converted into CK and F1, various natural plant components such as ginseng polysaccharide are reserved, and a specific synergistic effect is generated. Through verification, the prepared ginseng extract is high in bioavailability, can more effectively inhibit cell inflammation, and can more effectively recover the mitochondrial function of senescent cells and inhibit cell senescence. The preparation method provided by the invention is high in operability and easy to standardize and intellectualize. Compared with a traditional extraction and purification method, the adopted fermentation method is more environmentally friendly and efficient, and large-scale production can be achieved in industrial production.
Owner:TF BIOSYN BIOTECHNOLOGY CO LTD +1

Red ginseng processing method for increasing rare ginsenoside content and reducing pesticide residues

The invention provides a red ginseng processing method capable of increasing the content of rare ginsenoside and reducing pesticide residues, and relates to the technical field of medicinal material processing, the red ginseng processing method comprises the following steps: A, steaming fresh ginseng by using atomized probiotic fermentation liquor; b, drying the steamed fresh ginseng to obtain red ginseng; the pH (Potential of Hydrogen) of the probiotic fermentation liquor is 3.0 to 4.0; the OD600 value of the probiotic fermentation liquor is 1.2-2.5, the probiotic fermentation liquor is obtained through probiotic fermentation, the fermentation liquor with the pH value being 3.0-4.0 is adopted as an acid catalyst to replace purified water, in the ginseng steaming process, steaming is conducted through the atomized probiotic fermentation liquor, conversion of ginsenoside is promoted, and meanwhile organophosphorus pesticide residues in ginseng are degraded. The method is safe, efficient, green and natural, and loss of nutritional ingredients and functional ingredients caused by cooking is avoided. The technical problems that red ginseng processed and prepared in the prior art is low in rare saponin content and poor in effect and pesticide residues exist are solved.
Owner:KANGMEIHUA GENE TECH CO LTD +1

Pulsatilla saponin B4-oleanolic acid self-assembled nanoparticles as well as preparation and application thereof

The invention discloses pulsatilla saponin B4-oleanolic acid self-assembled nanoparticles as well as preparation and application thereof, and relates to the technical field of pharmaceutical preparations. Inspired by compatibility and solubilization of traditional Chinese medicines, the pulsatilla saponin B4-oleanolic acid self-assembled nanoparticles (AB4-OA NPs) are prepared by taking natural active components, namely micromolecular pulsatilla saponin B4 and oleanolic acid, as raw materials; the oleanolic acid has the effects of promoting dissolution and resisting inflammation, the water solubility of the oleanolic acid is improved, the bioavailability is improved, and the anti-inflammatory effect of the oleanolic acid is enhanced. Experimental results show that the AB4-OA NPs can effectively improve the dissolution rate of the oleanolic acid, so that the bioavailability of the oleanolic acid is effectively improved, meanwhile, the AB4-OA NPs has a better anti-inflammatory effect, and the effect is better than that of a single drug with the same dosage. In addition, the synthetic preparation method is simple and convenient, has the advantages of nano-scale drugs, realizes auxiliary-material-free pure drug self-delivery, and improves the delivery efficiency.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Combined leavening of ginseng, astragalus membranaceus and donkey-hide gelatin as well as preparation method and application of combined leavening

The invention provides a combined fermented product of ginseng, astragalus membranaceus and donkey-hide gelatin as well as a preparation method and application of the combined fermented product, and relates to the technical field of pharmaceutical preparations. The combined leavening is obtained by fermenting ginseng, astragalus membranaceus and donkey-hide gelatin, and the mass ratio of the ginseng to the astragalus membranaceus to the donkey-hide gelatin is (1-3): (10-30): 1. The composition of ginseng, astragalus membranaceus and colla corii asini is subjected to probiotic fermentation, macromolecular saponin is converted into aglycone or secondary saponin with smaller molecules, protein is split into peptide chains with smaller molecules, polysaccharide is split into sugar chains with smaller molecules, absorption and utilization of effective components of the medicine are facilitated, and the effect of tonifying qi and blood can be rapidly achieved.
Owner:ZHUHAI KAILI CHINESE HERBAL MEDICINES CO LTD

Method for producing transgenic plant with increased saponin content

The present invention relates to a method for producing a transgenic plant having an increased saponin content. It is confirmed that a nucleotide having a base sequence represented by SEQ ID NO: 1 or 2 derived from ginseng Panax ginseng increases ginsenoside accumulation by regulating the expression of genes involved in ginsenoside biosynthesis. Therefore, the method can be advantageously applied to the production of transgenic plants with increased saponin content.
Owner:PUSAN NAT UNIV IND UNIV COOPERATION FOUND

Bacteroides fragilis capable of converting ginsenoside Rb1 and ginsenoside Rd to obtain rare saponin aescin XVII and ginsenoside F2 and application of bacteroides fragilis

The invention discloses bacteroides fragilis capable of converting ginsenoside Rb1 and ginsenoside Rd to obtain rare saponin aescilloside XVII and ginsenoside F2 and application of the bacteroides fragilis CMLF03. The bacteroides fragilis CMLF03 is preserved in China General Microbiological Culture Collection Center, the preservation address is No.3, Yard 1, Beichen West Road, Chaoyang District, Beijing, and the preservation number is CGMCC NO. The preservation date is January 25, 2024, and the preservation number is CGMCC (China General Microbiological Culture Collection Center) NO.41094. The invention solves the problem of low conversion rate of the existing method for converting ginsenoside into rare ginsenoside. The bacteroides fragilis CMLF03 disclosed by the invention can be used for converting ginsenoside Rb1 and ginsenoside Rd to obtain rare saponin aescin XVII and ginsenoside F2.
Owner:YUNNAN NORMAL UNIV

Conjugates of saponin and antisense oligonucleotides for use in the treatment of neurodegenerative diseases

PCT designated stage expiredWO2024261042A1Senses disorderNervous disorderBiological targetNeural Canal
The present invention relates to the fields of therapy and drug delivery. More specifically, disclosed herein are therapeutic methods and pharmaceutical compositions for treating disorders of blood-tissue barrier-shielded organs that harbour substantive populations of post-mitotic neurons, such as the organs derived from neural tube that include the central nervous system and the eye. The disclosed methods and compositions involve localised administration into such organs of an effector component that targets an intracellular biological target, in combination with a saponin component that enhances effective uptake of the effector component into the cells and / or that enhances effective routing of the effector component inside the cells where the biological target is present. For example, the effector component can be an oligonucleotide therapeutic that is targeting a gene product associated with the disorder of the CNS and / or of the eye. Due to cellular uptake-stimulating and / or endosomal escape enhancing effects of the saponin component, the presented herein neuropharmaceutical and ophthalmic compositions for the localised administration into the CNS and / or into the eye, respectively, can be formulated with lower concentrations of the effector component and / or at lower volumes, which confers safety-benefits to the neurons and to the comfort of the patient.
Owner:SAPREME TECH BV

Penicillium photosporum LZ-3, fungicide and application of penicillium photosporum LZ-3 in biological control and growth promotion of panax notoginseng root rot

ActiveCN119120222AAlleviate continuous cropping obstaclespromote growthBiocidePlant growth regulatorsBiotechnologyContinuous cropping
The invention belongs to the technical field of biological bacterium agents, and particularly relates to a penicillium photosporum LZ-3, a bacterium agent and application of the penicillium photosporum LZ-3 in biological prevention and control and growth promotion of panax notoginseng root rot. The preservation number of the penicillium glabrata LZ-3 disclosed by the invention is CCTCC (China Center for Type Culture Collection) NO: M2024280. On the basis, the invention further provides a microbial inoculum containing the penicillium photosporum LZ-3, and the penicillium photosporum LZ-3 and the microbial inoculum containing the penicillium photosporum LZ-3 can effectively relieve continuous cropping obstacles of the panax notoginseng and antagonize fusarium fungi and sphaerotheca fungi so as to achieve the effect of preventing and controlling the root rot of the panax notoginseng. Meanwhile, the growth of the pseudo-ginseng can be promoted and the saponin content in the pseudo-ginseng can be increased.
Owner:YUNNAN AGRICULTURAL UNIVERSITY +1

Anti-inflammatory soothing cosmetic composition

ActiveCN121221507ACosmetic preparationsAntipyreticSpilanthesTamarix
The invention relates to the technical field of cosmetics, and discloses an anti-inflammatory soothing cosmetic composition which comprises the following components in percentage by weight: 0.5%-4% of a barrier repairing component, 0.5%-3% of an immunoregulation component, 0.3%-2.5% of a nerve soothing component, 0.3%-3% of an anti-inflammatory plant compound, 1%-10% of a moisturizing soothing enhancer and the balance of auxiliary materials. According to the components, through a five-dimensional synergistic mechanism of barrier repair, immune tolerance, nerve desensitization, anti-inflammatory itching relieving, moisturizing and stability maintaining, anti-inflammatory relieving and barrier repair are remarkably enhanced; ceramide, rare ginsenoside, phytosterol ester and free fatty acid are introduced to synergistically construct a bionic liposome which is closer to the composition of human cuticle lipid, so that the transdermal absorption and stability are enhanced, and the repair efficiency is remarkably improved; the dipotassium glycyrrhizinate, the tamarix chinensis flower extract, the purslane extract, the dinoflaxanthine and the baicalin cooperate to quickly resist inflammation and relieve itching and strengthen barrier repair, so that the composition is suitable for highly sensitive skin.
Owner:CAMPARI SCI & TECH (SUZHOU) CO LTD

Method for synchronously extracting tea seed oil and tea saponin from tea seeds

The invention provides a method for synchronously extracting tea seed oil and tea saponin from tea seeds, and belongs to the technical field of active substance extraction. According to the method, the extraction rate and the purity are remarkably improved by finely regulating and controlling the extraction conditions. The specific composite oil extraction auxiliary agent and the ultrasonic-assisted extraction technology are adopted, and the power, time and solvent ratio are optimized, so that the extraction efficiency and the product quality of the tea seed oil and the tea saponin are superior to those of the tea seed oil and the tea saponin prepared by a traditional method. Experimental data prove that the extraction rate of the tea seed oil reaches 27.22%, and the purity of the tea seed oil reaches 99.66%; the extraction rate of the tea saponin is 21.85%, and the purity of the tea saponin reaches 96.50%. By increasing the utilization rate of the raw materials and reducing the production cost, the market competitiveness of the product is improved, the high-quality tea seed oil and tea saponin meet the requirements of the market for natural products, and the tea seed oil and tea saponin have wide application prospects.
Owner:HENAN JINGUO BIOTECHNOLOGY CO LTD

Plant-source nutritional supplement based on glycoside compounds and preparation method of plant-source nutritional supplement

The invention discloses a plant-source nutritional supplement based on glycoside compounds and a preparation method thereof, and relates to the technical field of preparation of plant-source nutritional supplements.The preparation method comprises the steps that raw materials are prepared; the preparation method comprises the following steps: respectively carrying out ultrasonic-assisted extraction on flavonoid glycoside, saponin and geniposide raw materials to obtain an extracting solution; carrying out centrifugal separation on the extracting solution, taking supernate, and then purifying by adopting a macroporous resin adsorption method to obtain a purified glycoside compound solution; mixing the purified glycoside compound solution with lycium barbarum polysaccharide, Chinese yam starch, vitamin E and other auxiliaries in proportion, and uniformly stirring to form a mixed solution; carrying out spray drying on the mixed solution to obtain a powdery nutritional supplement; and screening the powdery nutritional supplement. The high-purity plant source glycoside compound and the functional auxiliary agent are scientifically compounded, and ultrasonic extraction, resin purification and precise process control are combined, so that the integrated improvement of activity synergy, quality stability and personalized scene adaptation of the nutritional supplement is realized.
Owner:HUBEI BOHAI BIO-HOLDING GROUP CO LTD

Preparation method and application of American ginseng metagen beverage rich in rare ginsenoside

The invention belongs to the technical field of medicine and health care, and particularly relates to a preparation method of an American ginseng root water extract rich in rare ginsenoside and application of the American ginseng root water extract in improving the immune and anti-tumor direction. The preparation method comprises the following steps: step 1, carrying out superfine grinding on American ginseng, and sieving; step 2, adding the American ginseng powder into water, and then adding compound enzyme for enzymolysis to obtain enzymatic hydrolysate; s3, after the enzymolysis is finished, heating the enzymatic hydrolysate, extracting twice, and mixing after the extraction is finished; and S4, inoculating compound lactic acid bacteria into the mixed solution, fermenting to obtain a fermentation solution, blending, and sterilizing to obtain the American ginseng afterbiogen beverage. According to the invention, a new physical-biological combined process is adopted, and crushing, enzymolysis, extraction, fermentation and blending are carried out, so that the American ginseng metagen beverage rich in rare ginsenoside is obtained, and the rare ginsenoside has a remarkable anti-tumor effect and higher activity.
Owner:WEIHAI ZIGUANG FIG TECH CO LTD

Immunologically active saponin fractions and adjuvant formulations

Disclosed are immunologically active saponin fraction composition, its method of manufacture and use in vaccine adjuvants, and in adjuvanted vaccines. Methods of preparation, vaccine and treatment kits comprising the adjuvants, and uses of vaccines and vaccine kits comprising the adjuvants are also disclosed.
Owner:VACCINE FORMULATION INST CH LTD +1

Method for constructing HPLC (High Performance Liquid Chromatography) contents of multi-index components of reference sample of traditional Chinese medicine powder

The invention relates to a method for constructing HPLC (High Performance Liquid Chromatography) contents of multi-index components of a reference sample of traditional Chinese medicine powder, which comprises the following steps: step 1, preparation of a reference sample of Kaixin powder: taking polygala tenuifolia, ginseng, poria cocos and rhizoma acori graminei, and crushing into fine powder; 2, preparing a Kaixin powder reference sample and a reference substance detection solution; 3, detecting the Kaixin powder reference sample and the reference substance detection liquid by adopting an HPLC (High Performance Liquid Chromatography) instrument to obtain a chromatogram; and step 4, calculating the content of the effective components in the Kaixin powder reference sample according to the chromatogram. Wherein in the step 3, an HPLC (High Performance Liquid Chromatography) instrument is adopted for detection, and a chromatogram is obtained; comprising the following steps: step A, detecting the contents of polygala # imgabs0 # ketone III, 3, 6 '-dimustard acyl sucrose and beta-asarone in rhizoma acori graminei in polygala tenuifolia; step B, detecting the contents of ginsenoside Rg1, ginsenoside Re and ginsenoside Rb1 in the ginseng; and step C, detecting the content of tenuifolin in the polygala tenuifolia.
Owner:JIANGSU EHAI PHARMA CORP

Application of centella glycosyl transferase gene in catalyzing glycosylation of asiatic acid and madecassic acid

The invention belongs to the technical field of plant genetic engineering, and particularly relates to application of a centella asiatica glycosyl transferase gene in catalyzing glycosylation of asiatic acid and madecassic acid. The nucleotide sequence of the gene is shown as SEQ ID No.1, and the protein coded by the gene can catalyze the C-28 site of asiatic acid and madecassic acid to perform glucose group modification so as to generate asiatic acid monoglucoside and madecassic acid monoglucoside, and preferentially catalyzes madecassic acid. By constructing a metabolic regulation network, the genes are widely and accurately screened, and the glycosylation process of catalyzing asiatic acid and madecassic acid is analyzed; an important reference basis is provided for improving the glycosylation efficiency of asiatic acid and madecassic acid and the yield of asiaticoside and madecassoside in the in-vitro synthesis and industrial production process of the centella asiatica triterpenoid saponin, and an important theoretical support is provided for large-scale production of the centella asiatica active saponin.
Owner:HAINAN UNIVERSITY SANYA NANFAN RESEARCH INSTITUTE

Glycosidase and application thereof in preparation of ginsenoside Rd

The invention discloses glycosidase and application of the glycosidase in preparation of ginsenoside Rd. The amino acid sequence of the glycosidase comprises a sequence as shown in SEQ ID NO. 1. The glycosidase catalyzes a complex feed liquid containing ginsenoside Rb1, the ginsenoside Rd is prepared through conversion in a neutral non-buffer system, the enzymatic activity is good, the process is simple, the reaction condition is mild, the conversion rate of the ginsenoside Rd can reach 71% or above, and the glycosidase is suitable for large-scale preparation and wide in application prospect.
Owner:QILU UNIVERSITY OF TECHNOLOGY (SHANDONG ACADEMY OF SCIENCES)

Antibody-oligonucleotide conjugate

The invention relates to a ligand-effector moiety provided with at least one saponin and antibody-effector moiety provided with at least one saponin. An aspect of the invention is a composition comprising the ligand-effector moiety provided with at least one saponin or the antibody-effector moiety provided with at least one saponin of the invention. The invention also relates to an antibody-drug conjugate comprising covalently linked saponin and to an antibody-oligonucleotide conjugate comprising covalently linked saponin. An aspect of the invention relates to a pharmaceutical composition comprising the ligand-effector moiety provided with at least one saponin or the antibody-effector moiety provided with at least one saponin of the invention, and optionally further comprising a pharmaceutically acceptable excipient. The invention also relates to the ligand-effector moiety provided with at least one saponin or the antibody-effector moiety provided with at least one saponin, for use as a medicament. The invention also relates to the ligand-effector moiety provided with at least one saponin or the antibody-effector moiety provided with at least one saponin of the invention for use in the treatment or prophylaxis of a cancer.
Owner:SAPREME TECH BV

Method for regulating and controlling ginseng adventitious root morphology and saponin accumulation

The embodiment of the invention provides a method for regulating and controlling the form of ginseng adventitious roots and saponin accumulation. The method comprises the following steps: (a) carrying out mutagenesis treatment on initial ginseng adventitious roots by using ethyl methane sulfonate (EMS); (b) performing multiple rounds of screening and subculture to obtain to-be-selected ginseng adventitious roots with different forms and saponin accumulation; and (c) determining one or more target genes for regulating and controlling the form of the ginseng adventitious root and saponin accumulation based on the ginseng adventitious root to be selected.
Owner:DALIAN PRACTICAL BIOTECH

Method for producing notoginsenoside and ginsenoside by utilizing panax notoginseng cotyledon embryo

The invention relates to a method for producing notoginsenoside and ginsenoside by utilizing panax notoginseng cotyledon embryos, and belongs to the technical field of plant adventitious root tissue culture. The method comprises the following steps: inducing embryogenic calluses by utilizing immature zygotic embryos of panax notoginseng; proliferating the panax notoginseng embryogenic callus on a plate culture medium; s2, putting the pseudo-ginseng embryogenic callus obtained in the step S2 into a liquid culture medium, carrying out cell dispersion, and sieving by using a sieve with the aperture of 24-30 meshes; a mechanical stirring type bioreactor is filled with a liquid culture medium, and the globular embryo and the heart-shaped embryo are placed in the mechanical stirring type bioreactor to be cultured; s3, recovering the filtrate in the step S3, filtering by using a screen with the aperture of 30-80 meshes and 80-150 meshes to obtain uniform panax notoginseng embryogenic cells, and differentiating the panax notoginseng embryogenic cells in a triangular flask for the step S4; and drying the cotyledon embryo obtained in the step S4 at 45 DEG C, and grinding into powder. According to the method, large-scale generation of cotyledon embryos can be completed only in 4-6 weeks, the production process is remarkably accelerated, the method is suitable for industrial batch production requirements, and the production efficiency is high.
Owner:KUNMING INST OF BOTANY CHINESE ACAD OF SCI +1

Method for improving health condition of mammal or farm animal

A method for improving health conditions of mammals or livestock by feeding, to the mammals or livestock, a licorice extract including: (A) glycyrrhizic acid, a glycyrrhizic acid derivative, glycyrrhetinic acid, and / or a glycyrrhetinic acid derivative; (B) licorice saponins other than (A); and (C) licorice flavonoids; (B) including at least a licorice saponin H2, a licorice saponin G2, and macedonoside A, (C) including at least liquiritin apioside, isoliquiritin apioside, and isoliquiritin, where feeding is of 0.017 g / day / head or more of the licorice saponin H2, 0.002 g / day / head or more of the licorice saponin G2, and 0.002 g / day / head or more of the macedonoside A, 0.001 g / day / head or more of the liquiritin apioside, 0.001 g / day / head or more of the isoliquiritin apioside, and 0.001 g / day / head or more of the isoliquiritin.
Owner:ONISHI TAKAO

Hedera helix extract as well as preparation method and application thereof

The preparation method comprises the following steps: extracting hedera helix leaves with 75%-85% ethanol, concentrating, adjusting the pH value to 9.5-11, standing, filtering to obtain a crude extract, passing the crude extract through a chromatographic column, and eluting with 60%-80% ethanol to obtain the hedera helix extract; the chromatographic column is an HPD100 macroporous resin column, a polyamide column or a C18 column. The invention also provides pharmaceutical application of the hedera helix extract. By optimizing the preparation process, anti-inflammatory components in the hedera helix raw material are enriched, the yield of the obtained extract is increased, the saponin content is reduced, but the anti-inflammatory effect of the obtained extract is better, and an unexpected technical effect is achieved. According to the invention, the technical prejudice of increasing the content of saponin in the prior art is overcome, the hedera helix extract with better anti-inflammatory effect and higher yield is obtained on the basis of simplifying the elution procedure, the anti-inflammatory activity of the extract is increased, the anti-inflammatory effect is better under the condition of the same weight of crude drug, the dosage is reduced, and the cost is reduced. The economic benefit and the utilization rate of the raw medicines are improved.
Owner:ZHEIJIANG CONBA CHINESE MEDICINE CO LTD

Medicine for repairing skin wound and preparation method thereof

The invention relates to a medicine for repairing skin wounds and a preparation method thereof, and belongs to the technical field of biological medicines.The medicine is prepared from, by mass, 25-30 parts of bee embryo peptide, 8-10 parts of alkannin derivative, 10-15 parts of armillaria mellea polysaccharide, 8-10 parts of inonotus obliquus polysaccharide, 6-8 parts of notoginsenoside and 5-7 parts of astragaloside. The bee fetus peptide is a product which is more than 500Da and is obtained by performing step-by-step enzymolysis on bee larva freeze-dried powder through trypsin and bacillus subtilis neutral protease to obtain enzymatic hydrolysate which is less than 3kDa, performing purification through a G-50 sephadex column, performing ultrafiltration and performing freeze-drying. The alkannin derivative is obtained by reacting alkannin with succinic anhydride and glucosamine-polyethylene glycol. A special method is adopted for preparing the bee embryo peptide and alkannin derivatives, the bee embryo peptide and alkannin derivatives are matched with other components to play a synergistic role, and the effects of high safety, high skin cell proliferation promoting capacity, excellent antibacterial performance and the like are achieved.
Owner:HUBEI SHUANGXING PHARMA CO LTD

80% mancozeb wettable powder and application thereof

ActiveCN119278940Afine powderHigh suspension rateBiocideFungicidesSodium phosphatesToxicology
The invention belongs to the field of pesticide preparations, and particularly relates to 80% mancozeb wettable powder and application thereof, and the 80% mancozeb wettable powder comprises the following components in percentage by weight: 75-85% of mancozeb, 1-5% of a dispersing agent, 1-3% of a wetting agent, 2-4% of a synergistic auxiliary agent, 0.3-1% of a deflocculating agent and the balance of filler, the dispersing agent is TERSPERSE 2700, the wetting agent is Terweet-1004, the synergistic auxiliary agent is composed of tea saponin, PVP-K30 and nekal BX, the deflocculating agent is sodium hexametaphosphate, and the filler is kaolin. Wherein the mass ratio of the tea saponin to the PVP-K30 to the nekal BX is (1-4): (1-4): (1-4). The wettable powder prepared by the invention is relatively fine, relatively high in suspension rate, relatively good in spreadability, relatively strong in adsorption capacity and resistant to rain wash, and a layer of compact protective medicine film can be formed on the surfaces of crops after the wettable powder is applied to prevent infection of pathogenic bacteria, so that excellent disease prevention and treatment effects are achieved.
Owner:SHANDONG LONGXI PLANT PROTECTION CO LTD

Red ginseng fermentation liquor as well as preparation method and application thereof

The invention belongs to the technical field of biological medicine, and particularly relates to red ginseng fermentation broth and a preparation method and application thereof.The preparation method of the red ginseng fermentation broth comprises the following steps that red ginseng powder is dissolved in water, and a red ginseng fermentation medium is obtained by breaking cell walls in red ginseng; mixing the seed solution of the plant lactobacillus and the seed solution of the fermentation mucus lactobacillus to obtain a compound strain seed solution; inoculating the compound strain seed solution into a red ginseng fermentation culture medium for fermentation culture to obtain a fermentation solution; centrifuging the fermentation liquor, collecting supernate, extruding and filtering the supernate, and collecting filtrate, so as to obtain the red ginseng fermentation liquor. According to the invention, compound strain fermentation is adopted, and a mechanical extrusion mode is combined to increase the content of total saponins of ginseng. According to the method disclosed by the invention, the concentration of the total saponins of ginseng is increased from 2.19 mg / mL to 7.53 mg / mL.
Owner:BAIHONG FUTURE FOOD TECHNOLOGY (WEIHAI) CO LTD

Bone joint repairing composition containing stem cell vesicles and application thereof

The invention discloses a bone joint repairing composition containing stem cell vesicles and application of the bone joint repairing composition, and relates to the technical field of bone joint repairing compositions.The bone joint repairing composition is prepared from, by weight, 90-110 parts of stem cell vesicles and 41-57 parts of thelenota ananas saponin Ananaside A. The stem cell vesicles and the thelenota ananas saponin Ananaside A are combined to form the bone joint repairing composition. The stem cell vesicles are extracellular vesicles derived from human amniotic mesenchymal stem cells. According to the bone joint repairing composition provided by the invention, the stem cell vesicles and the thelenota ananas saponin in a proper proportion are matched for use, so that the synergistic interaction between the stem cell vesicles and the thelenota ananas saponin is realized. Animal experiments show that the composition has a remarkable repairing effect on a rat model with bone and joint injuries, can effectively relieve bone and joint pain symptoms of rats, not only widens the application field of human amniotic mesenchymal stem cell-derived extracellular vesicles, but also provides a new clinical treatment means for bone and joint repairing.
Owner:SICHUAN XINBIXUE BIOTECHNOLOGY CO LTD

Novel herpes zoster vaccine composition and preparation method thereof

The invention discloses a novel herpes zoster vaccine composition and a preparation method, and belongs to the technical field of vaccines. The novel herpes zoster vaccine composition comprises gE protein and an adjuvant, the adjuvant is selected from at least one of an aluminum salt adjuvant, a saponin adjuvant, a TLR pathway agonist, an STING pathway agonist, an emulsion adjuvant and a liposome adjuvant. The invention also provides a preparation method of the composition. Compared with the prior art, the gE protein prepared by the method disclosed by the invention has the advantages that a protective matrix is jointly constructed by saccharides capable of forming a glassy state and a buffer system, and conformation is fixed through hydrogen bond replacement and vitrification in freezing and drying processes, so that interface-induced folding and aggregation are reduced; a small amount of surfactant weakens air-liquid and solid-liquid interfacial tension, terminal low-adsorption filtration reduces non-specific adsorption loss, and the monomer state and immunogenicity are maintained after redissolution.
Owner:JIANGSU WALVAX BIOTECHNOLOGY CO LTD